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Summary
Background Child stunting reduces survival and impairs neurodevelopment. We tested the independent and combined 
effects of improved water, sanitation, and hygiene (WASH), and improved infant and young child feeding (IYCF) on 
stunting and anaemia in in Zimbabwe.
Methods We did a cluster-randomised, community-based, 2 × 2 factorial trial in two rural districts in Zimbabwe. Clusters 
were defined as the catchment area of between one and four village health workers employed by the Zimbabwe Ministry 
of Health and Child Care. Women were eligible for inclusion if they permanently lived in clusters and were confirmed 
pregnant. Clusters were randomly assigned (1:1:1:1) to standard of care (52 clusters), IYCF (20 g of a small-quantity lipid-
based nutrient supplement per day from age 6 to 18 months plus complementary feeding counselling; 53 clusters), 
WASH (construction of a ventilated improved pit latrine, provision of two handwashing stations, liquid soap, chlorine, 
and play space plus hygiene counselling; 53 clusters), or IYCF plus WASH (53 clusters). A constrained randomisation 
technique was used to achieve balance across the groups for 14 variables related to geography, demography, water 
access, and community-level sanitation coverage. Masking of participants and fieldworkers was not possible. The 
primary outcomes were infant length-for-age Z score and haemoglobin concentrations at 18 months of age among 
children born to mothers who were HIV negative during pregnancy. These outcomes were analysed in the intention-to-
treat population. We estimated the effects of the interventions by comparing the two IYCF groups with the two non-
IYCF groups and the two WASH groups with the two non-WASH groups, except for outcomes that had an important 
statistical interaction between the interventions. This trial is registered with ClinicalTrials.gov, number NCT01824940.
Findings Between Nov 22, 2012, and March 27, 2015, 5280 pregnant women were enrolled from 211 clusters. 3686 children 
born to HIV-negative mothers were assessed at age 18 months (884 in the standard of care group from 52 clusters, 
893 in the IYCF group from 53 clusters, 918 in the WASH group from 53 clusters, and 991 in the IYCF plus WASH 
group from 51 clusters). In the IYCF intervention groups, the mean length-for-age Z score was 0·16 (95% CI 0·08–0·23) 
higher and the mean haemoglobin concentration was 2·03 g/L (1·28–2·79) higher than those in the non-IYCF 
intervention groups. The IYCF intervention reduced the number of stunted children from 620 (35%) of 1792 to 
514 (27%) of 1879, and the number of children with anaemia from 245 (13·9%) of 1759 to 193 (10·5%) of 1845. The 
WASH intervention had no effect on either primary outcome. Neither intervention reduced the prevalence of diarrhoea 
at 12 or 18 months. No trial-related serious adverse events, and only three trial-related adverse events, were reported.
Interpretation Household-level elementary WASH interventions implemented in rural areas in low-income countries 
are unlikely to reduce stunting or anaemia and might not reduce diarrhoea. Implementation of these WASH 
interventions in combination with IYCF interventions is unlikely to reduce stunting or anaemia more than 
implementation of IYCF alone.
Funding Bill & Melinda Gates Foundation, UK Department for International Development, Wellcome Trust, Swiss 
Development Cooperation, UNICEF, and US National Institutes of Health.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Globally, linear growth faltering (ie, stunting) is the most 
prevalent form of undernutrition.1,2 Stunting largely 
occurs between conception and age 24 months, when 
mean length-for-age Z scores among Asian and African 
children plummet to –2·0, with little change thereafter.1,2 
Stunting reduces child survival, edu ca tional attainment, 
and adult economic productivity.1,2 Furthermore, the 
offspring of adults who were stunted as children are at 
increased risk of stunting, creating an intergenerational 
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cycle of low human capital.1,2 Stunting has been largely 
intractable to targeted interventions. On average, 
complementary feeding interventions increase length-
for-age Z scores by 0·1,3 and elimination of all diarrhoea 
in the first 2 years of life is estimated to increase length by 
0·38 cm (or length-for-age Z scores by 0·13).4 Similar to 
stunting, childhood anaemia is prevalent among children 
younger than 2 years in Africa and Asia, and is a primary 
cause of cognitive delay.2 Increasing dietary iron intake 
reduces anaemia by 32–62%, which leaves a substantial 
proportion of disease unaddressed.2
The UNICEF framework for undernutrition has been 
a guiding document for nearly 30 years.5 It highlights 
inadequate dietary intake and disease as the immediate 
causes of child undernutrition, and specifies that a 
multisectoral approach that addresses both proximal 
and distal determinants is required. Based on this 
framework, integration of improved infant diets with 
improved water, sanitation, and hygiene (WASH) is a 
logical approach, because of the role of WASH in 
reducing morbidity, especially diarrhoea. Along with 
others,6 we7 further hypothesised that the adverse 
Research in context
Evidence before this study
Before this trial, a Review done for The Lancet Nutrition Series 
highlighted that child stunting is a highly prevalent condition 
with adverse short-term and long-term sequelae.  A systematic 
review of the literature showed that complementary feeding 
studies of improvements to the quality or quantity of infant diet 
could improve linear growth, but only moderately. That review 
was followed by an updated systematic review published just 
after our trial was completed; it showed that complementary 
feeding had an effect of 0·11 on length-for-age Z scores in 
food-secure populations, which is about 5–10% of the deficit 
experienced by Asian and African children. Finally, in seminal 
research done in The Gambia, child linear growth failure was 
strongly associated with indicators of environmental enteric 
dysfunction—increased gut permeability and systemic 
inflammation resulting from translocation of gut microbes. 
Although untested, the cause of environmental enteric 
dysfunction has been widely attributed to faecal–oral exposure 
resulting from living in conditions of poor water, sanitation, and 
hygiene (WASH). Before this trial, a meta-analysis of data from 
Demographic and Health Surveys for low-income and 
middle-income countries showed an association between linear 
growth and sanitation, but no randomised trials had been 
published in which the effect of sanitation on any child health 
outcome, including diarrhoea, had been tested. Additionally, 
many trials of handwashing with soap and chlorination of 
drinking water showed reductions in diarrhoea, but none 
reported the effects of these interventions on gut health or child 
growth. Since we began this trial, four published trials have 
assessed the effect of community-based sanitation on stunting. 
In two of these trials, both done in India, uptake of sanitation 
was low, the frequency of open defecation remained high, 
and no benefits for child health were reported in either. In a trial 
done in Indonesia, intervention uptake was modest. The 
intervention reduced diarrhoea but had no effect on linear 
growth. Finally, in a trial done in Mali, the intervention nearly 
doubled latrine coverage and substantially reduced the 
frequency of open defecation. It had no effect on diarrhoea, 
but increased length-for-age Z scores by 0·18. Most recently, 
the WASH Benefits trials in Bangladesh and Kenya tested the 
effect of six interventions (water treatment, handwashing, 
sanitation, all three WASH interventions together, infant 
feeding, and infant feeding plus all three WASH interventions) 
on linear growth and diarrhoea. In both trials, modest 
reductions in stunting were noted in the infant feeding group 
and the infant feeding plus WASH group, but no effects on linear 
growth were noted in any of the WASH-only group. Diarrhoea 
was reduced in all active groups in the Bangladesh trial except in 
the water treatment only group. None of the interventions 
reduced diarrhoea in the Kenya trial.
Added value of this study 
The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial 
was a 2 × 2 factorial cluster-randomised trial to test the 
independent and combined effects of improving infant diet and 
household WASH on length-for-age Z score and haemoglobin 
(primary outcomes) at 18 months of age. The WASH 
intervention included a play space to minimise geophagia and 
ingestion of chicken faeces by children in addition to 
conventional WASH interventions (sanitation, water treatment, 
handwashing, and hygienic preparation of food). The infant and 
young child feeding intervention included 20 g of a small-
quantity lipid-based nutrient supplement per day from 6 to 18 
months in addition to counselling that targeted key barriers to 
optimal infant feeding in this context. Intervention intensity (ie, 
frequency of contact between behaviour-change promoters and 
participants) was monthly. The IYCF intervention increased the 
mean length-for-age Z score by 0·16 (95% CI 0·08–0·23) and the 
mean haemoglobin concentration by 2·0 g/L (1·3–2·8), reduced 
stunting and anaemia, and improved ponderal growth 
compared with the non-IYCF interventions. The WASH 
intervention had no effect on these outcomes. Neither 
intervention reduced child diarrhoea or mortality. 
Implications of all the available evidence
Our trial provides further high-level evidence that elementary 
WASH interventions (ie, provision of point-of-use water 
chlorination, handwashing stations not connected to water 
supply, and improved pit latrines, with promotion of hygiene 
behaviours) delivered at the household level in rural areas of 
low-income countries are unlikely to reduce stunting and might 
not reduce diarrhoea. Implementation of these WASH 
interventions together with IYCF interventions will not reduce 
stunting more than implementation of IYCF alone.
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effects of poor WASH on growth are primarily mediated 
through environmental enteric dysfunction, a sub-
clinical condition of the small intestine characterised 
by blunted villi, intestinal inflam mation, and intestinal 
permeability.7 Environmental enteric dysfunction 
reduces nutrient absorption, triggers chronic systemic 
inflammation, and is seemingly ubiqui tous among 
people living in impoverished conditions in low-income 
and middle-income countries. We further hypothesised 
that a household WASH intervention targeting path-
ways of faecal–oral exposure in young children will 
reduce environmental enteric dysfunction, increase 
linear growth, and reduce anaemia by facilitating iron 
mobil isation and erythropoiesis. Finally, we hypothe-
sised that the beneficial effects of WASH on growth 
and anaemia will be additive to those of improving 
infant diets.2 The Sanitation, Hygiene, Infant Nutrition 
Efficacy (SHINE) trial was designed to test these 
hypotheses.
Methods
Study design and participants
The design and methods of SHINE have been reported 
previously,2 and the protocol and statistical analysis plan 
are available online. Briefly, SHINE was a cluster-
randomised, community-based 2 × 2 factorial trial in two 
contiguous rural districts in Zimbabwe (Chirumanzu 
and Shurugwi). The districts have a 15% prevalence of 
antenatal HIV8 and a high prevalence of schisto somiasis, 
but a very low prevalence of soil-transmitted helminths.9 
Rotavirus vaccination was introduced during the trial 
from May, 2014. Households are usually single-family 
dwellings surrounded by farm land. Before the trial, 
mean distance between households was 82·6 m,10 and 
population density was 18·6 people per km². Clusters 
were defined as the catchment area of between one 
and four village health workers (VHWs) employed by 
the Zimbabwe Ministry of Health and Child Care. 
Urban and uninhabited areas were excluded. Between 
Nov 22, 2012 and March 27, 2015, VHWs prospectively 
surveyed new pregnancies, established the date of last 
menstrual period, and referred pregnant women to 
SHINE research nurses, who enrolled eligible women. 
Women were eligible for inclusion if they permanently 
resided in a study cluster and were confirmed pregnant. 
During the recruitment period, the cutoff of gestational 
age for eligibility was gradually loosened (from 14 weeks’ 
gestational age to just before parturition) to maximise 
recruit ment (appendix). The Medical Research Council 
of Zimbabwe and the Institutional Review Board of the 
Johns Hopkins Bloomberg School of Public Health 
approved the study protocol. All partici pants provided 
written informed consent.
Randomisation and masking
Clusters were allocated (1:1:1:1) to one of four treatment 
groups: standard of care, infant and young child feeding 
(IYCF), WASH, or IYCF plus WASH. LHM, the study’s 
senior statistician, used a constrained randomisation 
technique11 to identify 5000 allocation schemes that 
achieved balance across the groups for 14 variables 
related to geography, demography, water access, and 
sanitation coverage, and also met bias and validity 
specifications (appendix). From these, ten allocations 
were randomly selected.  The final allocation was 
selected at a public randomisation event attended by 
elected representatives of the study districts. Masking of 
participants and fieldworkers was not possible because 
of the obvious visual differences between interventions, 
but investigators were blinded to treatment groups until 
the final analysis of each prespecified outcome.
Procedures
Interventions were informed by extensive formative 
research and piloting.12–15 Behaviour-change modules 
were delivered by group-specific VHWs, who underwent 
training for 20 days to deliver standard of care, 30 days to 
deliver WASH, 32 days to deliver IYCF, and 35 days to 
deliver IYCF plus WASH. All enrolled women were 
scheduled to receive 15 behaviour-change modules with 
specific messages and interactive tools from enrolment 
until 12 months after the birth of their children (roughly 
one visit per month). Other family members were also 
encouraged to participate. A sequential integrated 
longitudinal intervention was delivered, and at each 
visit, previous information was reviewed before new 
information was introduced. Previously missed modules 
were delivered before any new material. Between 
13 months and 17 months postnatal, VHWs continued 
monthly visits providing routine care. During these 
visits, VHWs informally encouraged participants to 
practise behaviours relevant to their treatment group, 
although formal modules were not implemented. At 
18 months, a review module was implemented in all 
treatment groups before the mother completed the trial.
In the standard-of-care group, VHWs promoted 
exclusive breastfeeding to 6 months,16 advised on 
neonatal care, and promoted uptake of Ministry of Health 
and Child Care services, including antenatal care, 
immunisations, and family planning. In the WASH 
group, VHWs delivered all the standard-of-care messages, 
plus information about safe disposal of faeces, hand-
washing with soap at key times, protection of infants 
from geophagia and ingestion of animal faeces, 
chlorination of drinking water (especially for infants), 
and hygienic preparation of complementary food. Add-
itionally, ventilated improved pit latrines were con-
structed and two handwashing stations were installed by 
community builders supervised by Ministry of Health 
and Child Care environmental health technicians within 
6 weeks of enrolment. A plastic mat and play yard (North 
States, Minneapolis, MN, USA) were delivered to the 
home by a trial logistician at 2 and 6 months postnatal, 
respectively, and VHWs made monthly deliveries of soap 
For the protocol and statistical 
analysis plan see https://osf.io/
w93hy
See Online for appendix
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from the time of the handwashing module (roughly 
30  weeks antenatal) and chlorine from the time of the 
water treatment module (4 months postnatal) until 
18 months postnatal. In the IYCF group, VHWs delivered 
all the standard-of-care messages plus infor mation about 
the importance of nutrition for infant health, growth, 
and development; feeding nutrient-dense food and 20 g 
of a small-quantity lipid-based nutrient supplement17 
(Nutriset, Malaumay, France) daily from age 6–18 months; 
processing foods to facilitate mastication and swallowing; 
feeding during illness; and dietary diversity. Participants 
also received monthly deliveries of 30 sachets of the 
small-quantity lipid-based nutrient supplement from 
VHWs from infant age 6 months to 18 months postnatal. 
In the combined group, participants received all 
standard-of-care, WASH, and IYCF interventions. 
Ventilated improved pit latrines were built for participants 
in the standard-of-care and IYCF groups after trial 
completion.
Research nurses made home visits at baseline (roughly 
2 weeks after mothers provided consent), 32 weeks’ 
gestation, and 1, 3, 6, 12, and 18 months post partum to 
assess maternal and household characteristics and trial 
outcomes. Intervention uptake was assessed at all visits 
and reported here as prespecified for the 12-month 
postnatal visit. At baseline, mothers’ height, weight, mid-
upper-arm circumference, and haemoglobin concen-
trations (with Hemocue, Ängelholm, Sweden) were 
measured. They were also tested for Schistosoma 
haematobium (by urinary microscopy) and HIV (via the 
rapid test algorithm). HIV-positive women were urged to 
seek immediate antenatal care for prevention of mother-
to-child transmission. Other maternal and household 
characteristics assessed included dietary diversity, food 
insecurity, household wealth, and maternal capabilities.18
Infant birth date, weight, and delivery details were 
transcribed from health facility records. We provided 
Tanita BD-590 (Arlington Heights, IL, USA) infant 
scales to all health institutions in the study area and 
trained facility staff in use of the scales. Gestational age 
at delivery was calculated from the date of the mother’s 
last menstrual period. Infant weight, length, head 
circumference, and mid-upper-arm circumference were 
measured at every postnatal visit (appendix). At the 
18-month postnatal visit (ie, the trial endpoint), 
haemoglobin concentrations were measured, and length 
was calculated as the median of three measurements. 
Nurses were standardised against a gold standard 
anthropometrist by measuring non-study children from 
the community during a quality-control session held 
every 6 months. Infant diarrhoea (three or more loose or 
watery stools in 24 h), dysentery (stool with blood or 
mucus), and acute respiratory infection (fast or difficult 
breathing) were assessed by 7-day maternal recall at 
postnatal visits. Infants with acute malnutrition or 
illness were referred to clinics. At the 18-month postnatal 
visit (ie, the trial endpoint), mothers and infants were 
visited anywhere in the country. However, in view of the 
household-based nature of interventions, intermediate 
visits were done only when the mother was available in 
the household where she consented.
Serious adverse events and adverse events were 
ascertained during data collection visits and by VHWs, 
and were referred to a senior research nurse who 
collected details. Events were reviewed by the study 
physician (AJP) to establish relatedness to trial 
interventions before reporting them to responsible 
institutional review boards. An independent data safety 
and monitoring board comprising two physicians from 
Zimbabwe and a statistician from the UK reviewed 
interim adverse event data.
Outcomes
We prespecified that primary trial inferences would be 
based on findings among infants born to mothers who 
were HIV negative during pregnancy. Primary outcomes 
were mean length-for-age Z score and haemoglobin 
concentration at 18 months (target age 76–80 weeks, 
allowable range 76–130 weeks) in all enrolled participants 
(intention-to-treat analysis). Secondary out comes were 
mean weight-for-age Z scores, weight-for-length Z scores, 
mid-upper-arm circumference-for-age Z scores, and head 
circumference-for-age Z scores; the proportion of infants 
who were stunted (ie, length-for-age Z score less than –2), 
severely stunted (ie, length-for-age Z score less than –3), 
anaemic (ie, haemoglobin concentration <105 g/L), 
severely anaemic (ie, haemo globin concentration <70 g/L), 
underweight (ie, weight-for-age Z scores less than –2), and 
wasted (ie, weight-for-height Z scores less than –2); mean 
prevalence of diarrhoea, dysentery, and acute respiratory 
infection based on 7-day maternal history at infant age 
12 months and 18 months; and cumulative mortality up to 
age 18 months.
Statistical analysis
The original sample size calculation was 4800 women to 
allow for 15% exclusion because of maternal HIV and 
20% loss because of fetal and infant deaths, withdrawal, 
and loss to follow-up. Actual recruitment was 10% higher 
than the sample size calculation to ensure sufficient 
power for sensitivity analyses. With a minimum of 
816 HIV-unexposed infants per group at 18 months, the 
trial was powered to detect a 0·2 difference in length-for-
age Z scores, a reduction of 8 percentage points in 
stunting, and a 2·6 g/L shift in haemoglobin for the 
marginal effect of either intervention, with 90% power 
and type 1 error of 5%.2 This calculation was based on an 
assumed coefficient of variation of the true proportions 
of 0·43, and an effective loss of 33% of sample size 
because of variability in cluster size.
All analyses were done on an intention-to-treat basis at 
the child level. For primary analyses, we used generalised 
estimating equations that accounted for within-cluster 
correlation and contained two dummy variables 
Articles
www.thelancet.com/lancetgh   Vol 7   January 2019 e136
representing the main effect of the IYCF intervention 
(the two IYCF groups compared with the two non-IYCF 
groups) and the WASH intervention (the two WASH 
groups compared with the two non-WASH groups), 
unadjusted for other covariates, with an exchangeable 
working correlation structure.11 Although the study was 
not powered to detect a statistical interaction between the 
two inter ventions, we estimated these interactions for 
each outcome. When the inter action was significant (ie, 
p<0·05 according to the Wald test) or had a sizeable point 
estimate (ie, relative risk [RR] >2 or <0·5 when comparing 
ratio-of-ratios, or difference-of-differences >0·25 SDs 
when comparing continuous outcomes), results were 
based on  a regression model with three dummy variables 
to represent IYCF, WASH, and IYCF plus WASH 
compared with standard of care instead of the model 
of two terms. In adjusted analyses we controlled for 
prespecified baseline covariates, which were initially 
assessed in bivariate analyses to identify those with an 
important association with the outcome (ie, p<0·2 or 
RR >2·0 or <0·5 for dichotomous outcomes, and p<0·2 
or difference >0·25 SDs for continuous outcomes). 
Selected covariates were entered in a multivariable 
regression model; a forward stepwise selection procedure 
was implemented with p<0·2 to enter. A log-binomial 
specification was used to facilitate estimation of RRs. 
Depending on the analysis, other methods for com-
parison of groups while accounting for within-cluster 
correlation included multinomial and ordinal regression 
models with robust variance estimation, and Somers’ D 
for medians.
In a per-protocol analysis, we examined the effect of 
the interventions when behaviour-change modules 
were delivered at high fidelity (which was predefined 
Figure: Trial profile
SOC=standard of care. IYCF=infant and young child feeding. WASH=water, sanitation, and hygiene. *212 clusters were randomly assigned, 53 in each of the four trial 
groups. After randomisation, one cluster was excluded because it was in an urban area, one was excluded because the village health workers covering it mainly had 
clients outside the study area, and two more were merged on the basis of subsequent data for village health worker coverage. Three new cluster designations were 
created because of anomalies in the original mapping. For two of these clusters, the trial group was clear; the third contained areas that were in two trial groups, and 
was assigned to the under-represented group, resulting in 53 clusters in each group. All these changes occurred before enrolment began. When enrolment was 
completed, however, no women were enrolled in one cluster in the SOC group and thus 211 clusters were available for analysis.
1070 livebirths born to 1056
HIV-negative women in 
51 clusters
79 infants excluded from 
analysis
56 died
22 lost to follow-up
1 left trial 
996 livebirths born to 979
HIV-negative women in 
53 clusters
78 infants excluded from
analysis
50 died
27 lost to follow-up
1 left trial
963 livebirths born to 954 
HIV-negative women in 
53 clusters 
70 infants excluded from 
analysis
42 died
27 lost to follow-up
1 left trial
960 livebirths born to 948
HIV-negative women in 
52 clusters 
991 infants assessed in 51 clusters 
at 18 months
918 infants assessed in 53 clusters 
at 18 months 
893 infants assessed in 53 clusters
at 18 months 
884 infants assessed in 52 clusters 
at 18 months
76 infants excluded from 
analysis
50 died
24 lost to follow-up
2 left trial
1396 women in 53 clusters
assigned to IYCF plus WASH 
340 women excluded
9 left trial
10 lost to follow-up
74 miscarried
21 had stillbirths
205 were HIV positive
20 had unknown HIV 
status
1 died
1317 women in 53 clusters
assigned to WASH 
338 women excluded
12 left trial
21 lost to follow-up
53 miscarried
29 had stillbirths
200 were HIV positive
23 had unknown HIV
status
1289 women in 53 clusters 
assigned to IYCF 
5270 pregnant women enrolled from 
211* randomised clusters 
11 erroneously enrolled twice
for one pregnancy 
1 erroneously enrolled once for
two pregnancies 
5280 pregnant women enrolled from 
210* randomised clusters 
335 women excluded
14 left trial
28 lost to follow-up
66 miscarried
37 had stillbirths
155 were HIV positive
32 had unknown HIV 
status
3 died 
1268 women in 52 clusters 
assigned to SOC
320 women excluded
14 left trial
31 lost to follow-up
56 miscarried
14 had stillbirths
166 were HIV positive
39 had unknown HIV 
status 
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for the IYCF plus WASH group as receiving ten core 
modules and for the other study groups as receiving all 
modules scheduled at the same timepoints when IYCF 
plus WASH core modules were delivered). Several 
sensitivity analyses were prespecified: exclusion of 
mothers enrolled before Nov 1, 2013, to account for 
initial delays in latrine construction; exclusion of 
children born to women who were HIV negative during 
pregnancy but HIV positive at 18 months; and 
restriction of analyses to children in whom primary 
outcomes were measured during tight infant age 
windows (ie, at age 76–80 weeks and 76–100 weeks). A 
prespecified subgroup analysis of primary outcomes by 
infant sex was planned if the interaction terms were 
significant.
We used Stata (version 14.1) for all analyses. This trial is 
registered with ClinicalTrials.gov, number NCT01824940.
Role of the funding source
The study funders approved the trial design, but had no 
roles in data collection, analysis, or interpretation, or 
writing of the report. The corresponding author had full 
access to all study data and had final responsibility for 
the decision to submit for publication.
Standard of care Infant and young 
child feeding
Water, sanitation, 
and hygiene
Water, sanitation, and 
hygiene plus infant and 
young child feeding 
Mothers 948 954 979 1056
Infants 960 963 996 1070
Mothers completing baseline visit 866 867 943 1013
Household characteristics
Median number of occupants (IQR) 5 (3–6) 5 (4–6) 5 (3–6) 5 (3–6)
Wealth quintile19
1 (lowest) 189/858 (22%) 132/861 (15%) 189/935 (20%) 170/1005 (17%)
2 163/858 (19%) 156/861 (18%) 181/935 (19%) 206/1005 (20%)
3 171/858 (20%) 187/861 (22%) 178/935 (19%) 207/1005 (21%)
4 169/858 (20%) 188/861 (22%) 202/935 (22%) 208/1005 (21%)
5 (highest)  166/858 (19%) 198/861 (23%) 185/935 (20%) 214/1005 (21%)
Electricity
Power grid 26/855 (3%) 33/857 (4%) 26/938 (3%) 15/1006 (1%)
Other power source 
Solar 548/855 (64%) 584/858 (68%) 653/938 (70%) 698/1006 (69%)
Generator 22/855 (3%) 34/858 (4%) 31/938 (3%) 31/1006 (3%)
No electricity 285/855 (33%) 240/858 (28%) 254/938 (27%) 277/1006 (28%)
Sanitation
Household members defecate in the open 1924/3602 (53%) 1854/3900 (48%) 1916/4009 (48%) 1988/4354 (46%)
Any latrine at household 280/852 (33%) 346/850 (41%) 331/917 (36%) 367/987 (37%)
Improved latrine at household 245/852 (29%) 301/849 (35%) 293/914 (32%) 318/986 (32%)
Improved latrine with well trodden path not shared with 
other households and not used for storage
178/829 (21%) 233/817 (29%) 229/886 (26%) 250/952 (26%) 
Water
Main source of household drinking water improved 529/855 (62%)  558/854 (65%) 567/923 (61%) 639/993 (64%)
Treated drinking water to make safer 118/840 (14%) 108/836 (13%) 109/912 (12%) 114/980 (12%)
Median one-way walk time to fetch water (IQR), min 10 (5–20) 10 (5–18) 10 (5–20) 10 (5–20)
Mean water volume collected per person in past 24 h (SD), L 9·5 (10·5) 9·6 (8·6) 9·9 (16·6) 9·6 (10·0)
Hygiene
Handwashing station at household 37/796 (5%) 20/812 (2%) 121/885 (14%) 130/940 (14%)
Handwashing station with water and rubbing agent 10/793 (1%) 1/812 (<1%) 8/884 (1%) 10/938 (1%) 
Improved floor* 442/845 (52%) 481/851 (57%) 516/921 (56%) 557/990 (56%)
Median number of chickens (IQR) 6 (2–10) 7 (2–12) 6 (2–10) 5 (2–10)
Livestock observed inside home 324/859 (38%) 345/861 (40%) 341/931 (37%) 363/1003 (36%)
Faeces observed in the yard 271/855 (32%) 323/857 (38%) 274/928 (30%) 268/995 (27%)
Diet quality and food security
Household meets minimum Diet Diversity Score20 292/769 (38%) 326/744 (44%) 323/833 (39% ) 353/878 (40%)
Median Coping Strategies Index score21 (IQR) 1 (0–7) 0 (0–6) 1 (0–7) 1 (0–7)
(Table 1 continues on next page)
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Results
5280 pregnant women were enrolled from 211 clusters at 
a median gestational age of 12 (IQR 9–16) weeks (figure). 
During the antenatal period, 11 women were excluded 
and one woman was added to the analysis to correct for 
enrolment errors (figure). 139 (3%) women left the trial 
or were lost to follow-up, four (<1%) died, 249 (5%) 
miscarried, and 101 (2%) had stillbirths. 726 (14%) 
women tested positive for HIV and 114 (2%) had 
unknown HIV statuses during pregnancy, and were thus 
excluded from the analysis (outcomes for these infants 
will be reported separately). Thus 3989 infants were 
born alive to 3937 HIV-negative women and were 
included in our analysis. During the postnatal period, 
198 (5%) infants died. 3686 (97%) of the remaining 
3791 liveborn infants were assessed at the 18-month 
endpoint (5 [<1%] left the trial and 100 [3%] were lost to 
follow-up or moved outside Zimbabwe).
At baseline, nearly half of all household members 
practised open defecation and about a third of 
households had an improved latrine (table 1). Very few 
had electricity from the grid but two-thirds had a solar 
panel (typically for phone charging; table 1). Water access 
was poor: nearly 40% of households obtained drinking 
water from unimproved sources, and about 40% had a 
return-trip walk to their water source of greater than 
30 min (data not shown). The mean volume collected 
was 9·5 L per person per day (table 1). Walking time to 
water was not associated with volume collected (data 
not shown). Mothers had completed a median of more 
than 9 years of schooling, were mostly married,  and 
roughly 10% were infected with S haematobium (table 1). 
Mean infant birthweight was 3·1 kg (SD 0·5), and nearly 
90% were born via institutional deliveries (table 1). The 
frequency of open defecation was higher—and wealth 
index scores, rates of employment and latrine ownership, 
and diet quality were lower—in mothers in the standard-
of-care group than in those in the other groups. Other 
maternal and household baseline characteristics and all 
infant birth characteristics were similar across treatment 
groups (table 1).
Fidelity of intervention delivery was high (table 2). 
Among households in the WASH groups, more than 
98% received ventilated improved pit latrines and 
handwashing stations, more than 92% received play 
mats and play yards, and nearly 80% received 80% or 
more of the planned deliveries of soap and chlorine 
solution (table 2). Among households in the IYCF 
groups, 79% received ≥80% of planned deliveries of the 
small-quantity lipid-based nutrient supplement (table 2). 
Among households in the WASH groups and IYCF 
groups, mothers received a median of 15 (IQR 13–15) of 
Standard of care Infant and young 
child feeding
Water, sanitation, 
and hygiene
Water, sanitation, and 
hygiene plus infant and 
young child feeding 
(Continued from previous page)
Maternal characteristics
Mean age (SD), years 25·4 (8·5) 25·7 (7·6) 25·6 (8·5) 25·9 (8·1)
Mean height (SD), cm 156·0 (6·1) 160·1 (5·9) 159·5 (8·0) 159·6 (10·2)
Mean mid-upper-arm circumference (SD), cm 26·3 (3·2) 26·5 (3·2) 26·4 (3·6) 26·5 (3·3)
Positive microscopy for Schistosoma haematobium 78/824 (9%) 80/820 (10%) 116/878 (13%) 104/958 (11%) 
Mean years of schooling completed (SD) 9·6 (2·2) 9·7 (2·8) 9·5 (2·0) 9·6 (2·5) 
Median parity (IQR) 2 (1–3) 2 (1–3) 2 (1–3) 2 (1–3) 
Married 850/894 (95%) 852/892 (96%) 886/933 (95%) 958/998 (10%)
Employed 53/857 (6%) 81/857 (9%) 91/936 (10%) 86/1006 (9%)
Religion 
Apostolic 459/899 (51%) 395/903 (44%)  440/939 (47%) 469/1004 (47%)
Other Christian 383/899 (43%) 444/903 (49%) 410/939 (44%) 447/1004 (45%)
Other 57/899 (6%) 64/903 (7%) 89/939 (9%) 88/1004 (9%)
Infant characteristics
Female sex 474/959 (49%) 472/958 (49%) 487/995 (49%) 529/1062 (50%)
Mean birthweight (SD), kg 3·1 (0·6) 3·10 (0·49) 3·09 (0·54) 3·10 (0·50)
Birthweight <2500 g 79/855 (9%) 76/864 (9%) 86/892 (10%) 84/962 (9%)
Institutional delivery 752/855 (88%) 761/861 (88% ) 794/892 (89%) 854/948 (90%)
Vaginal delivery 814/874 (93%) 812/870 (93%) 833/904 (92%) 897/967 (93%)
Baseline variables are presented for mothers who had livebirths. Maternal and household data were collected about 2 weeks after consent was recorded (at roughly 14 weeks’ 
gestation). This gap created opportunity for loss to follow-up between consent and baseline; thus, the number of mothers completing baseline visit is less than the number 
of mothers with livebirths. Baseline for infants was birth. Data are n or n (%), unless otherwise specified. *Improved floor defined as concrete, brick, cement, or tile; 
unimproved floor defined as mud, earth, sand, or dung.
Table 1: Maternal, household, and infant baseline characteristics of HIV-negative mothers and their liveborn infants
Articles
e139 www.thelancet.com/lancetgh   Vol 7   January 2019
Da
ta
 so
ur
ce
St
an
da
rd
 o
f 
ca
re
IY
CF
W
AS
H
IY
CF
 p
lu
s 
W
AS
H
Co
m
bi
ne
d 
W
AS
H
N
on
-W
AS
H
p 
va
lu
e*
Co
m
bi
ne
d 
IY
CF
N
on
-IY
CF
p 
va
lu
e*
Fi
de
lit
y 
of
 in
te
rv
en
ti
on
 d
el
iv
er
y
Ch
ild
re
n 
w
ith
 1
8-
m
on
th
 o
ut
co
m
es
 (o
n 
w
ho
m
 in
fe
re
nc
es
 a
re
 b
as
ed
), 
n
Tr
ia
l l
og
s
88
4
89
3
91
8
99
1
19
09
17
77
18
84
18
02
W
AS
H
 su
pp
lie
s
SH
IN
E-
in
st
al
le
d 
ve
nt
ila
te
d 
im
pr
ov
ed
 
pi
t l
at
rin
e
Tr
ia
l l
og
s
N
A
N
A
90
1/
91
8 
(9
8%
)
97
4/
99
1 
(9
8%
)
18
75
/1
90
9 
(9
8%
)
N
A
··
N
A
N
A
··
Tw
o 
ha
nd
w
as
hi
ng
 st
at
io
ns
 (T
ip
py
 
Ta
ps
) d
el
iv
er
ed
Tr
ia
l l
og
s
N
A
N
A
91
2/
91
8 
(9
9%
)
98
6/
99
1 
(9
9%
)
18
98
/1
90
9 
(9
9%
)
N
A
··
N
A
N
A
··
Ba
by
 m
at
 d
el
iv
er
ed
Tr
ia
l l
og
s
N
A
N
A
85
9/
91
8 
(9
4%
)
94
2/
99
1 
(9
5%
)
18
01
/1
90
9 
(9
4%
)
N
A
··
N
A
N
A
··
Pl
ay
 ya
rd
 d
el
iv
er
ed
Tr
ia
l l
og
s
N
A
N
A
84
7/
91
8 
(9
2%
)
92
6/
99
1 
(9
3%
)
17
73
/1
90
9 
(9
3%
)
N
A
··
N
A
N
A
··
M
ed
ia
n 
liq
ui
d 
so
ap
 d
el
iv
er
ie
s (
IQ
R)
† 
Tr
ia
l l
og
s
N
A
N
A
20
 (1
6–
20
)
20
 (1
8–
20
)
20
 (1
7–
20
)
N
A
··
N
A
N
A
··
Re
ce
iv
ed
 ≥
80
%
 o
f e
xp
ec
te
d 
so
ap
 
de
liv
er
ie
s
Tr
ia
l l
og
s
N
A
N
A
70
9/
91
8 
(7
7%
)
80
1/
99
1 
(8
1%
)
15
10
/1
90
9 
(7
9%
)
N
A
··
N
A
N
A
··
M
ed
ia
n 
W
at
er
 G
ua
rd
 d
el
iv
er
ie
s (
IQ
R)
‡ 
Tr
ia
l l
og
s
N
A
N
A
15
 
(1
3–
15
)
15
 
(1
4–
15
)
15
 
(1
4–
15
)
N
A
··
N
A
N
A
··
Re
ce
iv
ed
 ≥
80
%
 o
f e
xp
ec
te
d 
W
at
er
 
Gu
ar
d 
de
liv
er
ie
s
Tr
ia
l l
og
s
N
A
N
A
72
4/
91
8 
(7
9%
)
79
9/
99
1 
(8
1%
)
47
23
2/
52
65
6 
(8
0%
)
N
A
··
N
A
N
A
··
IY
CF
 su
pp
lie
s
M
ed
ia
n 
de
liv
er
ie
s o
f s
m
al
l-q
ua
nt
ity
 
lip
id
-b
as
ed
 n
ut
rie
nt
 su
pp
le
m
en
t (
IQ
R)
§
Tr
ia
l l
og
s
N
A
13
 
(1
2–
13
)
N
A
13
 
(1
2–
13
)
N
A
N
A
··
13
 
(1
2–
13
)
N
A
··
Re
ce
iv
ed
 ≥
11
 (8
0%
 o
f e
xp
ec
te
d)
 
de
liv
er
ie
s o
f s
m
al
l-q
ua
nt
ity
 li
pi
d-
ba
se
d 
nu
tr
ie
nt
 su
pp
le
m
en
t 
Tr
ia
l l
og
s
N
A
69
5/
89
3 
(7
8%
)
N
A
79
0/
99
1 
(8
0%
)
N
A
N
A
··
14
85
/1
88
4 
(7
9%
)
N
A
··
Be
ha
vi
ou
r c
ha
ng
e 
m
od
ul
es
M
ed
ia
n 
in
te
rv
en
tio
n 
m
od
ul
es
 (I
Q
R)
‡
Vi
lla
ge
 h
ea
lth
 
w
or
ke
r r
ep
or
t
15
 
(1
3–
15
)
15
 
(1
3–
15
)
14
 
(1
3–
15
)
15
 
(1
4–
15
)
15
 
(1
3–
15
)
15
 
(1
3–
15
)
0·
32
1
15
 
(1
3–
15
)
15
 
(1
3–
15
)
0·
00
09
Co
m
pl
et
ed
 in
te
rv
en
tio
n 
m
od
ul
es
Vi
lla
ge
 h
ea
lth
 
w
or
ke
r r
ep
or
t
14
 6
64
/1
6 
52
3  
(8
9%
)
19
 6
73
/2
2 1
62
 
(8
8·
8%
)
20
 6
36
/2
3 2
37
 
(8
9%
)
26
 59
6/
29
 4
19
 
(9
0%
)
47
 23
2/
52
 6
56
 
(9
0%
)
34
 33
7/
38
 6
85
 
(8
9%
)
0·
32
1
46
 26
9/
51
 58
1  
(9
0%
%
)
35
 30
0/
39
 76
0  
(8
9%
)
0·
34
7
Pa
rt
ic
ip
an
t u
pt
ak
e 
of
 p
ro
m
ot
ed
 b
eh
av
io
ur
s a
t t
he
 1
2-
m
on
th
 v
is
it
M
ot
he
rs
 w
ith
 o
ut
co
m
es
 a
t 1
2 
m
on
th
s 
an
d 
18
 m
on
th
s, 
n
Tr
ia
l l
og
s
67
5
70
2
65
2
73
1
13
83
13
77
··
14
33
13
27
··
Ch
ild
re
n 
w
ith
 o
ut
co
m
es
 a
t 1
2 
m
on
th
s 
an
d 
18
 m
on
th
s, 
n
Tr
ia
l l
og
s
68
2
70
6
66
2
74
1
14
03
13
88
··
14
47
13
44
··
(T
ab
le
 2
 co
nt
in
ue
s o
n 
ne
xt
 p
ag
e)
Articles
www.thelancet.com/lancetgh   Vol 7   January 2019 e140
Da
ta
 so
ur
ce
St
an
da
rd
 o
f 
ca
re
IY
CF
W
AS
H
IY
CF
 p
lu
s 
W
AS
H
Co
m
bi
ne
d 
W
AS
H
N
on
-W
AS
H
p 
va
lu
e*
Co
m
bi
ne
d 
IY
CF
N
on
-IY
CF
p 
va
lu
e*
(C
on
tin
ue
d 
fro
m
 p
re
vi
ou
s p
ag
e)
W
AS
H
 b
eh
av
io
ur
s
H
ou
se
ho
ld
 m
em
be
rs
 w
ho
 d
ef
ec
at
e 
in
 
th
e o
pe
n
M
at
er
na
l r
ep
or
t
10
88
/2
40
7 
(4
5%
)
10
57
/2
78
9 
(3
8%
)
27
/2
91
7 
(1
%
)
23
/3
35
9 
(1
%
)
50
/6
27
6 
(1
%
)
50
/6
27
6 
(1
%
)
<0
·0
00
1
N
A
N
A
··
An
y 
la
tr
in
e 
at
 h
ou
se
ho
ld
O
bs
er
va
tio
n
21
4/
66
5 
(3
2%
)
29
1/
68
3 
(4
3%
)
64
2/
64
8 
(9
9%
)
72
5/
72
7 
(>
99
%
)
13
67
/1
37
5 
(9
9%
)
50
5/
13
48
 
(3
7%
)
<0
·0
00
1
N
A
N
A
··
Im
pr
ov
ed
 la
tr
in
e 
at
 h
ou
se
ho
ld
O
bs
er
va
tio
n
18
5/
66
4 
(2
8%
)
24
6/
68
3 
(3
6%
)
64
2/
64
8 
(9
9%
)
72
3/
72
7 
(>
99
%
)
13
65
/1
37
5 
(9
9%
)
43
1/
13
47
 
(3
2%
)
<0
·0
00
1
N
A
N
A
··
Im
pr
ov
ed
 la
tr
in
e w
ith
 w
el
l t
ro
dd
en
 
pa
th
 n
ot
 sh
ar
ed
 w
ith
 o
th
er
 h
ou
se
ho
ld
s 
an
d 
no
t u
se
d 
fo
r s
to
ra
ge
O
bs
er
va
tio
n 
an
d 
m
at
er
na
l r
ep
or
t
14
4/
66
2 
(2
2%
)
18
2/
68
2 
(2
7%
)
55
7/
64
7 
(8
6%
)
62
4/
72
6 
(8
6%
)
11
81
/1
37
3 
(8
6%
)
32
6/
13
44
 
(2
4%
)
<0
·0
00
1
N
A
N
A
··
H
an
dw
as
hi
ng
 st
at
io
n 
at
 h
ou
se
ho
ld
O
bs
er
va
tio
n
38
/6
40
 
(6
%
)
41
/6
63
 
(6
%
)
64
1/
65
3 
(9
8%
)
72
1/
73
4 
(9
8%
)
13
62
/1
38
7 
(9
8%
)
79
/1
30
3 
(6
%
)
<0
·0
00
1
N
A
N
A
··
H
an
dw
as
hi
ng
 st
at
io
n 
w
ith
 w
at
er
 a
nd
 
ru
bb
in
g 
ag
en
t a
t h
ou
se
ho
ld
O
bs
er
va
tio
n
6 
(3
%
)
13
/6
54
 
(2
%
)
51
3/
61
5 
(8
3%
)
56
0/
66
9 
(8
4%
)
10
73
/1
28
4 
(8
4%
)
31
/1
28
6 
(2
%
)
<0
·0
00
1
N
A
N
A
··
Ev
er
 tr
ea
ts
 d
rin
ki
ng
 w
at
er
 to
 m
ak
e 
sa
fe
r
M
at
er
na
l r
ep
or
t
90
/6
67
 
(1
3%
)
77
/6
84
 
(1
1%
)
56
7/
65
0 
(8
7%
)
63
0/
72
7 
(8
7%
)
11
97
/1
37
7 
(8
7%
)
16
7/
13
51
 
(1
2%
)
<0
·0
00
1
N
A
N
A
··
Di
sp
os
es
 w
at
er
 fr
om
 cl
ea
ni
ng
 in
fa
nt
 
na
pp
ie
s w
ith
 fa
ec
es
 in
 a
 la
tr
in
e
M
at
er
na
l r
ep
or
t
18
5/
66
0 
(2
8%
23
9/
67
1 
(3
6%
)
47
8/
63
4 
(7
5%
)
55
8/
71
1 
(7
8%
)
10
36
/1
34
5 
(7
7%
)
42
4/
13
31
 
(3
2%
)
<0
·0
00
1
N
A
N
A
··
Pl
ay
 sp
ac
e 
is 
vi
sib
ly
 cl
ea
n 
O
bs
er
va
tio
n
N
A
N
A
56
3/
61
5 
(9
2%
)
63
8/
68
8 
(9
3%
)
12
01
/1
30
3 
(9
2%
)
N
A
N
A
N
A
N
A
··
Ch
ild
 e
ve
r o
bs
er
ve
d 
to
 e
at
 so
il
M
at
er
na
l r
ep
or
t
51
8/
66
3 
(7
8%
)
47
0/
69
1 
(6
8%
)
16
6/
64
5 
(2
6%
)
19
9/
72
5 
(2
7%
)
36
5/
13
70
 
(2
7%
)
98
8/
13
54
 
(7
3%
)
<0
·0
00
1
N
A
N
A
··
Ch
ild
 e
ve
r o
bs
er
ve
d 
to
 e
at
 ch
ick
en
 
fa
ec
es
M
at
er
na
l r
ep
or
t
15
2/
66
3 
(2
3%
)
13
1/
68
9 
(1
9%
)
19
/6
46
 
(3
%
)
17
/7
24
 
(2
%
)
36
/1
37
0 
(3
%
)
28
3/
13
52
 
(2
1%
)
<0
·0
00
1
N
A
N
A
··
IY
CF
 b
eh
av
io
ur
s
Ch
ild
 st
ill
 b
re
as
tf
ee
di
ng
M
at
er
na
l r
ep
or
t
65
5/
67
7 
(9
7%
)
67
5/
69
5 
(9
7%
)
63
4/
65
3 
(9
7%
)
70
3/
73
4 
(9
6%
)
N
A
N
A
-
13
78
/1
42
9 
(9
6%
)
12
89
/1
33
0 
(9
7%
)
0·
49
4
M
ot
he
r r
ep
or
ts
 co
rre
ct
 w
ay
s t
o 
fe
ed
 
ch
ild
 d
ur
in
g 
an
d 
af
te
r i
lln
es
s
M
at
er
na
l r
ep
or
t
42
4/
67
3 
(6
3%
)
48
5/
69
0 
(7
0%
)
39
3/
64
7 
(6
1%
)
49
9/
72
9 
(6
8%
)
N
A
N
A
-
98
4/
14
19
 
(6
9%
)
81
7/
13
20
 
(6
2%
)
<0
·0
00
1
In
fa
nt
 d
ie
t m
et
 m
in
im
um
 d
ie
ta
ry
 
di
ve
rs
ity
 in
 p
as
t 2
4 
h 
M
at
er
na
l r
ep
or
t
34
3/
65
6 
(5
2%
)
46
0/
67
0 
(6
9%
)
33
8/
62
7 
(5
4%
)
49
6/
70
0 
(7
1%
)
N
A
N
A
-
95
6/
13
70
 
(7
0%
)
68
1/
12
83
 
(5
3%
)
<0
·0
00
1
In
fa
nt
 co
ns
um
ed
 ir
on
-r
ich
 fo
od
 in
 p
as
t 
24
 h
M
at
er
na
l r
ep
or
t
33
3/
66
4 
(5
0%
)
66
5/
69
2 
(9
6%
)
30
9/
64
3 
(4
8%
)
69
7/
72
9 
(9
6%
)
N
A
N
A
-
13
62
/1
42
1 
(9
6%
)
64
2/
13
07
 
(4
9%
)
<0
·0
00
1
In
fa
nt
 co
ns
um
ed
 a
ni
m
al
 so
ur
ce
 fo
od
 in
 
pa
st
 2
4 
h
M
at
er
na
l r
ep
or
t
41
9/
66
7 
(6
3%
)
48
3/
68
8 
(7
0%
)
39
4/
64
0 
(6
2%
)
50
8/
71
9 
(7
1%
)
N
A
N
A
-
99
1/
14
07
 
(7
0%
)
81
3/
13
07
 
(6
2%
)
<0
·0
00
1
In
fa
nt
 co
ns
um
ed
 v
ita
m
in
-A
-r
ich
 fo
od
 
in
 p
as
t 2
4 
h
M
at
er
na
l r
ep
or
t
46
9/
66
8 
(7
0%
)
54
0/
68
8 
(7
8%
)
43
4/
64
3 
(6
7%
)
57
1/
71
9 
(7
9%
)
N
A
N
A
-
11
11
/1
40
7 
(7
9%
)
90
3/
13
11
 
(6
9%
)
<0
·0
00
1
N
ut
rib
ut
te
r c
on
su
m
ed
 in
 p
as
t 2
4 
h
M
at
er
na
l r
ep
or
t
N
A
63
4/
66
8 
(9
5%
) 
N
A
64
5/
71
4 
(9
0%
)
N
A
N
A
-
11
11
/1
40
7 
(7
9%
)
N
A
··
Da
ta
 a
re
 n
/N
 (%
), 
un
le
ss
 o
th
er
w
ise
 sp
ec
ifi
ed
. T
he
 d
en
om
in
at
or
 fo
r i
nd
ict
or
s o
f fi
de
lit
y o
f i
nt
er
ve
nt
io
n 
de
liv
er
y 
ar
e t
he
 n
um
be
r o
f c
hi
ld
re
n 
w
ho
 p
ro
vi
de
d 
18
-m
on
th
 o
ut
co
m
es
, b
ec
au
se
 in
fe
re
nc
es
 o
f t
ria
l o
ut
co
m
es
 a
re
 b
as
ed
 o
n 
th
es
e 
ch
ild
re
n.
  T
he
 
de
no
m
in
at
or
 fo
r i
nd
ica
to
rs
 o
f p
ar
tic
ip
an
t u
pt
ak
e o
f p
ro
m
ot
ed
 b
eh
av
io
ur
s a
t t
he
 1
2-
m
on
th
 v
isi
t a
re
 th
e 
nu
m
be
r o
f w
om
en
 (f
or
 h
ou
se
ho
ld
-le
ve
l i
nd
ica
to
rs
) a
nd
 ch
ild
re
n 
(fo
r c
hi
ld
-le
ve
l i
nd
ica
to
rs
) w
ho
 p
ro
vi
de
d 
12
-m
on
th
 a
nd
 1
8-
m
on
th
 o
ut
co
m
es
.  
Vi
lla
ge
 h
ea
lth
 w
or
ke
rs
 w
er
e 
sc
he
du
le
d 
to
 v
isi
t h
ou
se
ho
ld
s m
on
th
ly
 to
 d
el
iv
er
 3
0 
sa
ch
et
s o
f a
 sm
al
l-q
ua
nt
ity
 li
pi
d-
ba
se
d 
nu
tr
ie
nt
 su
pp
le
m
en
t (
su
ffi
cie
nt
 to
 p
ro
vi
de
 2
0 
g 
pe
r d
ay
), 
1 
L o
f l
iq
ui
d 
so
ap
, a
nd
 1
50
 m
L 
(o
ne
 b
ot
tle
) o
f W
at
er
 G
ua
rd
 fo
r f
am
ili
es
 o
f 
le
ss
 th
an
 fi
ve
 p
eo
pl
e 
(t
w
o 
bo
tt
le
s f
or
 fa
m
ili
es
 o
f fi
ve
 o
r m
or
e 
pe
op
le
). 
Th
e 
co
m
bi
ne
d 
W
AS
H
 g
ro
up
 co
m
pr
ise
d 
th
e t
w
o 
W
AS
H
-c
on
ta
in
in
g 
gr
ou
ps
, w
he
re
as
 th
e 
no
n-
W
AS
H
 g
ro
up
 co
m
pr
ise
d 
th
e t
w
o 
gr
ou
ps
 n
ot
 in
clu
di
ng
 W
AS
H
.  T
he
 co
m
bi
ne
d 
IY
CF
 g
ro
up
 
co
m
pr
ise
d 
th
e t
w
o 
IY
CF
-c
on
ta
in
in
g 
gr
ou
ps
, w
he
re
as
 th
e 
no
n-
IY
CF
 g
ro
up
 co
m
pr
ise
d 
th
e t
w
o 
gr
ou
ps
 n
ot
 in
clu
di
ng
 IY
CF
. I
YC
F=
in
fa
nt
 a
nd
 yo
un
g 
ch
ild
 fe
ed
in
g.
 W
AS
H
=w
at
er
, s
an
ita
tio
n,
 a
nd
 h
yg
ie
ne
. S
H
IN
E=
Sa
ni
ta
tio
n,
 H
yg
ie
ne
, I
nf
an
t N
ut
rit
io
n 
Effi
ca
cy
 
tr
ia
l. 
N
A=
no
t a
pp
lic
ab
le
. *
p 
va
lu
es
 w
er
e 
ad
ju
st
ed
 fo
r c
lu
st
er
in
g 
eff
ec
t; 
de
pe
nd
in
g 
on
 th
e 
va
ria
bl
e t
yp
e,
 xt
ge
e,
 m
ul
tin
om
ia
l, o
rd
in
al
 re
gr
es
sio
n 
m
od
el
s w
ith
 ro
bu
st
 v
ar
ia
nc
e 
es
tim
at
io
n,
 a
nd
 S
om
er
s’ 
D 
fo
r m
ed
ia
ns
, w
er
e u
se
d 
fo
r c
om
pa
rin
g 
ar
m
s w
hi
le
 
ac
co
un
tin
g 
fo
r w
ith
in
-c
lu
st
er
 co
rre
la
tio
n.
 †
M
ax
im
um
 o
f 2
0 
de
liv
er
ie
s. 
‡M
ax
im
um
 o
f 1
5 
de
liv
er
ie
s. 
§M
ax
im
um
 o
f 1
3 
de
liv
er
ie
s.
Ta
bl
e 2
: I
nt
er
ve
nt
io
n 
de
liv
er
y 
an
d 
pa
rt
ic
ip
an
t u
pt
ak
e 
by
 tr
ea
tm
en
t g
ro
up
Articles
e141 www.thelancet.com/lancetgh   Vol 7   January 2019
the 15 intervention visits scheduled between enrolment 
and 12 months postnatal.  Thus, the intervention dose 
(ie, frequency of contact) was about once per 5 weeks. 
Intervention uptake was assessed at 12 months, when 
74% of the women were available for the visit (table 2). 
Women assessed at 12 months were, on average, older, 
slightly wealthier, more likely to be married and have a 
diverse diet, and had higher parity than women not 
assessed at the 12-month visit (appendix). Baseline 
indicators of sanitation, water, and hygiene were similar 
(appendix).
At the 12 months post-partum visit, the frequency 
of open defecation among household members in 
the WASH groups was 1% compared with 41% in non-
WASH groups (table 2). Nearly all households in 
WASH groups had an improved latrine, and in 86% of 
households the latrine had a well trodden path and was 
not being used for storage (compared with 24% in non-
WASH groups). 84% of households in the WASH 
groups had a handwashing station with observed soap 
or rubbing agent and water compared with 2% of 
households in non-WASH groups (table 2). 1197 (87%) 
of 1372 women in the WASH groups reported that they 
usually treated their drinking water. However, too few 
samples of water were tested for free chlorine to 
objectively validate water chlorination. Of the 752 water 
Effects by individual 
treatment group
Main effects combining groups Unadjusted 
difference (95% CI)
p value Adjusted difference* 
(95% CI)
p value
n Mean (SD) Treatment 
group
n Mean (SD)*
Length-for-age Z score
SOC 878 –1·57 (1·08) No IYCF 1792 –1·59 (1·08) Ref ·· Ref ··
IYCF 891 –1·47 (1·06) IYCF 1879 –1·44 (1·06) 0·16 (0·08 to 0·23) <0·0001 0·14 (0·07 to 0·21) <0·0001
WASH 914 –1·61 (1·07) No WASH 1769 –1·52 (1·07) Ref ·· Ref ··
IYCF plus WASH 988 –1·41 (1·06) WASH 1902 –1·50 (1·07) 0·02 (–0·06 to 0·09) 0·698 0·06 (–0·01 to 0·12) 0·119
Haemoglobin (g/dL) 
SOC 866 116·5 (11·3) No IYCF 1759 116·3 (11·8) Ref ·· Ref ··
IYCF 882 118·4 (11·2) IYCF 1845 118·3 (11·5) 2·03 (1·28 to 2·79) <0·0001 1·94 (1·22 to 2·67) <0·0001
WASH 893 116·1 (12·4) No WASH 1748 117·5 (11·3) Ref ·· Ref ··
IYCF plus WASH 963 118·3 (11·8) WASH 1856 117·2 (12·1) –0·28 (–1·04 to 0·48) 0·471 –0·60 (–1·37 to 0·17) 0·128
Weight-for-age Z score
SOC 875 –0·72 (1·02) No IYCF 1785 –0·75 (1·02) Ref ·· Ref ··
IYCF 888 –0·66 (1·02) IYCF 1871 –0·62 (0·99) 0·13 (0·07 to 0·20) <0·0001 0·13 (0·07 to 0·19) <0·0001
WASH 910 –0·78 (1·02) No WASH 1763 –0·69 (1·02) Ref ·· Ref ··
IYCF plus WASH 983 –0·59 (0·97) WASH 1893 –0·68 (1·00) 0·00 (–0·06 to 0·07) 0·911 0·00 (–0·06 to 0·06) 0·971
Weight-for-height Z score
SOC 875 0·05 (1·07) No IYCF 1782 0·02 (1·05) Ref ·· Ref ··
IYCF 888 0·06 (1·11) IYCF 1870 0·09 (1·07) 0·08 (0·00 to 0·15) 0·036 0·08 (0·02 to 0·15) 0·016
WASH 907 –0·01 (1·04) No WASH 1763 0·06 (1·09) Ref ·· Ref ··
IYCF plus WASH 982 0·11 (1·04) WASH 1889 0·05 (1·04) –0·01 (–0·08 to 0·07) 0·875 –0·04 (–0·11 to 0·03) 0·257
Mid-upper-arm circumference Z score
SOC 870 0·03 (0·90) No IYCF 1779 0·01 (0·92) Ref ·· Ref ··
IYCF 889 0·05 (0·87) IYCF 1871 0·07 (0·84) 0·07 (0·01 to 0·13) 0·033 0·07 (0·01 to 0·14) 0·018
WASH 909 –0·01 (0·92) No WASH 1759 0·04 (0·88) Ref ·· Ref ··
IYCF plus WASH 982 0·09 (0·82) WASH 1891 0·04 (0·88) 0·00 (–0·06 to 0·06) 0·999 0·01 (–0·05 to 0·07) 0·745
Head-circumference-for-age Z score
SOC 872 –0·26 (1·08) No IYCF 1778 –0·26 (1·08) Ref ·· Ref ··
IYCF 885 –0·23 (1·07) IYCF 1868 –0·19 (1·06) 0·07 (0·00 to 0·14) 0·043 0·06 (0·00 to 0·13) 0·053
WASH 906 –0·27 (1·09) No WASH 1757 –0·24 (1·07) Ref ·· Ref ··
IYCF plus WASH 983 –0·16 (1·06) WASH 1889 –0·21 (1·08) 0·03 (–0·04 to 0·10) 0·372 0·08 (0·01 to 0·15) 0·018
SOC=standard of care. IYCF=infant and young child feeding. Ref=reference. WASH=water, sanitation, and hygiene. *Prespecified baseline variables considered for inclusion in 
adjusted analyses were maternal age, mid-upper-arm circumference, years of schooling, marital status, employment, religion, maternal capabilities, haemoglobin 
concentration, household Coping Strategy Index, proportion of household members practising open defecation, faeces observed in yard, household floor type, time to fetch 
drinking water, chicken ownership, livestock observed inside house, number of household occupants, wealth index quintile, infant low versus normal birthweight, infant sex, 
and preterm birth; the study factors data collector and calendar year of enrolment were also considered for inclusion. 
Table 3: Effect of WASH and IYCF interventions on infant growth and haemoglobin concentrations at age 18 months (primary and secondary continuous 
outcomes)
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samples from WASH households that were tested at 12 
months, only 438 (58%) had more than 0·1 parts per 
million  of free chlorine. Compared with infants in the 
non-IYCF groups, a higher proportion of those in the 
IYCF groups had diets that met minimum dietary 
diversity and had consumed animal-source, iron-rich, 
and vitamin-A-rich foods in the previous 24 h (table 2). 
93% of children in the IYCF groups consumed the 
small-quantity lipid-based nutrient supplement in the 
previous 24 h (table 2).
At the 18-month visit, median child age was 18·0 months 
(IQR 17·8–18·8) and did not differ significantly across 
treatment groups (data not shown). There was no statistical 
interaction between the two treatments for any outcome at 
18 months, so the main effects of the IYCF and WASH 
interventions are presented.  All follow-up was completed by 
July 31, 2017. At 18 months, the mean length-for-age Z score 
was 0·16 (95% CI 0·08–0·23) higher and mean 
haemoglobin concentration was  2·0 g/L (1·28–2·79) 
higher in children in the IYCF groups than in those in the 
non-IYCF groups (table 3). These differences were slightly 
attenuated in adjusted analyses (table 3). The IYCF 
intervention reduced stunting by 7·2 percentage points 
(95% CI 4·3–10·2)—620 (35%) of 1792 children in the 
non-IYCF groups vs 514 (27%) of 1879 children in the 
IYCF groups. The IYCF intervention also reduced anaemia 
by 3·5 percentage points (1·3–5·6)—245 (14%) of 
1759 children in the non-IYCF groups vs 194 (11%) of 
Effects by individual 
treatment group
Main effects combining groups Unadjusted RR 
(95% CI)
p value Adjusted RR* 
(95% CI)
p value
n Prevalence (%) Treatment 
group
n Prevalence (%)
Stunting (length-for-age Z score less than –2·0)
SOC 878 292 (33%) No IYCF 1792 620 (35%) Ref ·· Ref ··
IYCF 891 249 (28·0%) IYCF 1879 514 (27%) 0·79 (0·72–0·87) <0·0001 0·80 (0·73–0·88) <0·0001
WASH 914 328 (36%) No WASH 1769 541 (31%) Ref ·· Ref ··
IYCF plus WASH 988 265 (27%) WASH 1902 593 (31%) 1·03 (0·93–1·13) 0·596 0·99 (0·90–1·09) 0·818
Severe stunting (length-for-age Z score less than –3·0)
SOC 878 74 (8%) No IYCF 1792 160 (9%) Ref ·· Ref ··
IYCF 891 72 (8%) IYCF 1879 139 (7%) 0·83 (0·66–1·04) 0·109 0·85 (0·67–1·07) 0·173
WASH 914 86 (9%) No WASH 1769 146 (8%) Ref ·· Ref ··
IYCF plus WASH 988 67 (7%) WASH 1902 153 (8%) 0·99 (0·78–1·24) 0·908 0·96 (0·75–1·23) 0·769
Anaemia (haemoglobin <105 g/L)
SOC 866 117 (14%) No IYCF 1759 245 (14%) Ref ·· Ref ··
IYCF 882 81 (9%) IYCF 1845 193 (10%) 0·75 (0·62–0·90) 0·003 0·76 (0·63–0·92) 0·004
WASH 893 128 (14%) No WASH 1748 198 (11%) Ref ·· Ref ··
IYCF plus WASH 963 112 (12%) WASH 1856 240 (13%) 1·14 (0·95–1·36) 0·151 1·13 (0·93–1·37) 0·235
Severe anaemia (haemoglobin <70 g/L)
SOC 866 3 (<1%) No IYCF 1759 5 (<1%) Ref ·· ··† ··
IYCF 882 0 (0%) IYCF 1845 1 (<1%) 0·19 (0·02–1·62) 0·129 ·· ··
WASH 893 2 (<1%) No WASH 1748 3 (<1%) Ref ·· ··
IYCF plus WASH 963 1 (<1%) WASH 1856 3 (<1%) 0·96 (0·20–4·71) 0·959 ·· ··
Underweight (weight-for-age Z score less than –2·0)
SOC 875 83 (9%) No IYCF 1785 189 (11%) Ref ·· Ref ··
IYCF 888 74 (8%) IYCF 1871 147 (8%) 0·74 (0·60–0·91) 0·005 0·76 (0·62–0·94) 0·010
WASH 910 106 (12%) No WASH 1765 157 (9%) Ref ·· Ref ··
IYCF plus WASH 983 73 (7%) WASH 1893 179 (9%) 1·07 (0·87–1·31) 0·539 1·08 (0·87–1·34) 0·464
Wasted (weight-for-height Z score less than –2·0)
SOC 875 25 (3%) No IYCF 1782 48 (3%) Ref ·· Ref ··
IYCF 888 24 (3%) IYCF 1870 43 (2%) 0·86 (0·57–1·29) 0·459 0·83 (0·55–1·27) 0·381
WASH 907 23 (3%) No WASH 1763 49 (3%) Ref ·· Ref ··
IYCF plus WASH 982 19 (2%) WASH 1889 42 (2%) 0·80 (0·53–1·21) 0·291 0·88 (0·55–1·39) 0·571
RR=relative risk. SOC=standard of care. IYCF=infant and young child feeding. Ref=reference. WASH=water, sanitation, and hygiene. *Prespecified baseline variables considered for 
inclusion in adjusted analyses were maternal age, mid-upper-arm circumference, years of schooling, marital status, employment, religion, maternal capabilities, haemoglobin 
concentration, household Coping Strategy Index, proportion of household members practising open defecation, faeces observed in yard, household floor type, time to fetch 
drinking water, chicken ownership, livestock observed inside house, number of household occupants, wealth index quintile, infant low versus normal birthweight, infant sex, and 
preterm birth; the study factors data collector and calendar year of enrolment were also considered for inclusion. †Insufficient data to run a regression model.
Table 4: Effect of WASH and IYCF interventions on infant growth and haemoglobin concentrations at age 18 months (secondary dichotomous outcomes)
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1845 children in the IYCF groups—and significantly 
increased mean weight-for-age, weight-for-height, and 
head-circumference-for-age Z scores (tables 3, 4) compared 
with the non-IYCF interventions.
The WASH intervention had no effect on the mean 
infant length-for-age Z score or mean haemoglobin 
concentration compared with the non-WASH 
interventions (table 3). The WASH interventions had 
no significant effects on any other growth measure-
ments except for mean head-circumference-for-age 
Z scores in adjusted analyses (table 3); however, this 
effect was driven entirely by the IYCF plus WASH 
group. Coefficient of variation estimates from random-
effects models were 0·012 for stunting and 0·12 for 
anaemia, and 0·16 and 0, respectively, by method-of-
moments estimation.
At the 12-month visit, there was a significant statistical 
interaction between the IYCF and WASH interventions 
for 7-day prevalence of diarrhoea and acute respiratory 
infection, so the IYCF, WASH, and IYCF plus WASH 
groups were each compared with the standard-of-care 
group (table 5).  The 7-day prevalence of diarrhoea was 
9% in the standard-of-care group, 13% in the IYCF 
group, 12% in the WASH group, and 10% in the IYCF 
plus WASH group (table 5). The prevalence of diarrhoea 
was 37% (95% CI 4–80) higher in the IYCF group than 
in the standard-of-care group (p=0·03). No significant 
differences were noted between the standard-of-care 
group and the IYCF group, the WASH group, or the 
IYCF plus WASH group in the prevalence of acute 
respiratory infection (table 5). There were only eight 
cases of dysentery overall (one in the standard-of-care 
group, three in the WASH group, and four in the IYCF 
plus WASH group). 
At 18 months, there was no interaction between 
the two treatments, so the main effects of the two 
interventions are presented (table 6).  The prevalence of 
n Prevalence Difference vs SOC (95% CI)
Unadjusted p value Adjusted* p value
Diarrhoea
SOC 678 62 (9%) Ref ·· Ref ··
IYCF 696 87 (13%) 1·37 (1·04–1·80) 0·027 1·32 (1·00–1·75) 0·054
WASH 666 77 (12%) 1·26 (0·92–1·71) 0·151 1·18 (0·87–1·61) 0·292
IYCF plus WASH 735 76 (10%) 1·13 (0·84–1·53) 0·422 1·05 (0·79–1·40) 0·716
Acute respiratory infection
SOC 676 6 (1%) Ref ·· Ref ··
IYCF 694 2 (<1%) 0·32 (0·07–1·52) 0·154 0·34 (0·07–1·70) 0·193
WASH 662 8 (1%) 1·36 (0·51–3·63) 0·539 1·75 (0·62–4·90) 0·289
IYCF plus WASH 735 7 (1%) 1·07 (0·35–3·26) 0·899 1·38 (0·42–4·47) 0·595
SOC=standard of care. Ref=reference. IYCF=infant and young child feeding. WASH=water, sanitation, and hygiene. 
*Prespecified baseline variables considered for inclusion in adjusted analyses were maternal age, mid-upper-arm 
circumference, years of schooling, marital status, employment, religion, maternal capabilities, haemoglobin 
concentration, household Coping Strategy Index, proportion of household members practising open defecation, 
faeces observed in yard, household floor type, time to fetch drinking water, chicken ownership, livestock observed 
inside house, number of household occupants, wealth index quintile, infant low versus normal birthweight, infant sex, 
and preterm birth; the study factors data collector and calendar year of enrolment were also considered for inclusion. 
Table 5: Effect of IYCF and WASH interventions on diarrhoea and acute respiratory infection at age 
12 months 
n Prevalence Main effects combining groups Unadjusted 
difference (95% CI)
p value Adjusted* difference  
(95% CI)
p value
Treatment 
group
n Prevalence
Diarrhoea
SOC 874 83 (9%) No IYCF 1784 176 (10%) Ref ·· Ref ··
IYCF 883 65 (7%) IYCF 1866 175 (9%) 0·95 (0·77–1·16) 0·585 0·97 (0·79–1·19) 0·750
WASH 910 93 (10%) No WASH 1757 148 (8%) Ref ·· Ref ··
IYCF plus WASH 983 110 (11%) WASH 1893 203 (11%) 1·28 (1·04–1·57) 0·020 1·15 (0·93–1·41) 0·191
Acute respiratory infection
SOC 875 6 (1%) No IYCF 1785 11 (1%) Ref ·· Ref ··
IYCF 879 4 (<1%) IYCF 1856 9 (<1%) 0·77 (0·28–2·13) 0·617 0·76 (0·28–2·03) 0·582
WASH 910 5 (1%) No WASH 1754 10 (1%) Ref ·· Ref ··
IYCF plus WASH 977 5 (1%) WASH 1887 10 (1%) 0·96 (0·36–2·55) 0·930 1·29 (0·48–3·43) 0·611
Death
SOC 959 50 (5%) No IYCF 1954 99 (5%) Ref ·· Ref ··
IYCF 958 40 (4%) IYCF 2020 92 (5%) 0·88 (0·66–1·18) 0·406 0·87 (0·65–1·18) 0·376
WASH 995 49 (5%) No WASH 1917 90 (5%) Ref ·· Ref ··
IYCF plus WASH 1062 52 (5%) WASH 2057 101 (5%) 1·04 (0·78–1·39) 0·790 0·96 (0·72–1·30) 0·808
SOC=standard of care. IYCF=infant and young child feeding. Ref=reference. WASH=water, sanitation, and hygiene. *Prespecified baseline variables considered for inclusion in 
adjusted analyses were maternal age, mid-upper-arm circumference, years of schooling, marital status, employment, religion, maternal capabilities, haemoglobin 
concentration, household Coping Strategy Index, proportion of household members practising open defecation, faeces observed in yard, household floor type, time to fetch 
drinking water, chicken ownership, livestock observed inside house, number of household occupants, wealth index quintile, infant low versus normal birthweight, infant sex, 
and preterm birth; the study factors data collector and calendar year of enrolment were also considered for inclusion.
Table 6: Effect of IYCF and WASH interventions on diarrhoea, acute respiratory infection, and mortality at age 18 months
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diarrhoea did not differ between the IYCF groups 
and non-IYCF groups, but was 28% higher in the 
WASH groups than in the non-WASH groups—a 
difference was significant in unadjusted but not 
adjusted analyses (table 6). Neither IYCF nor WASH 
significantly affected the prevalence of acute respiratory 
infection (table 6), and only ten cases of dysentery (two 
in the standard-of-care group, three in the IYCF group, 
two in the WASH group, and three in the IYCF plus 
WASH group) were recorded.
Cumulative mortality at 18 months was 5·2% in the 
standard-of-care group, 4·2% in the IYCF group, 4·9% in 
the WASH group, and 4·9% in the IYCF plus WASH 
group, and did not differ significantly between groups. 
Treatment group effects on length-for-age Z scores, 
haemoglobin concentrations, stunting, anaemia, and 
diarrhoea prevalence were similar in all prespecified 
sensitivity analyses compared with those in the total 
analytic sample (data not shown). However, in the 
prespecified subgroup analysis by infant sex, boys had 
poorer linear growth than girls at 18 months, with lower 
mean length-for-age Z scores (–1·66 [95% CI 
–1·72 to –1·61] vs –1·35 [–1·40 to –1·30]) and a higher 
proportion of stunting (36·7% [34·4 to 39·0] vs 25·0% 
[23·1 to 27·2]). Child sex modified the effects of the IYCF 
intervention on length-for-age Z scores (pinteraction=0·016) 
but not stunting (pinteraction=0·420). The IYCF intervention 
was more efficacious in increasing mean length-for-age 
Z scores among boys (0·24 [95% CI 0·14 to 0·34]) than 
among girls (0·07 [95% CI –0·04 to 0·17]). Child sex did 
not modify the effect of the IYCF intervention on 
haemoglobin concentration or anaemia, or the effect of 
the WASH intervention on either primary outcome (data 
not shown).
Among 653 serious adverse events, none were judged 
to be related to the trial interventions (appendix). Three 
adverse events were judged to be related to trial 
interventions (one possibly related, one probably related, 
and one definitely related). In the IYCF group, a child 
with congenital abnormalities complained of abdominal 
discomfort after ingestion of the small-quantity lipid-
based nutrient supplement (possibly related). In the 
IYCF plus WASH group, one child had diarrhoea after 
consumption of the small-quantity lipid-based nutrient 
supplement (probably related). In the WASH group, one 
child was fed WaterGuard by a sibling (definitely related). 
The child was reviewed at the clinic and treated 
with paracetamol for 3 days. All three cases resolved 
completely with no sequelae.
Discussion
We tested the independent and combined effects of an 
infant feeding intervention and a household WASH 
intervention on attained child length and haemoglobin 
concentration at 18 months of age. Interventions were 
delivered with  high fidelity of intervention and sub-
stantial contrast was achieved in WASH and IYCF 
hardware, commodities, and behaviours. Consistent with 
decades of complementary feeding research,3,22 the IYCF 
inter ventions increased linear growth and haemoglobin 
concentrations, reduced stunting by 21%, reduced 
anaemia by 24%, and increased head circumference 
and ponderal growth compared with the non-IYCF 
interventions. Although we could not separate out the 
effects of complementary feeding education from those 
of the lipid-based nutrient supplement, our formative 
work showed that both components are important.12,13 
By contrast, we detected no benefit for the WASH 
intervention on any reported child health outcomes. 
Length-for-age Z scores, haemo globin concentrations, 
proportions of stunted and anaemic children, and 
indicators of ponderal growth were similar in WASH 
and non-WASH groups. Head circumference at the 
18-month visit was greater in the WASH than in the non-
WASH groups in adjusted analyses, but this difference 
was driven by the IYCF plus WASH group, and was thus 
unlikely to be a true WASH effect.
The IYCF intervention did not decrease the 7-day 
prevalence of diarrhoea at either the 12-month or 18-month 
visits. We think that the increased diarrhoea prevalence in 
the IYCF group at 12 months was a chance occurrence. 
Although diarrhoea risk is moderately increased by oral 
iron when given as a medicinal supplement, this risk is 
nearly absent when iron is given as a food fortificant.23 
The WASH intervention had no effect on diarrhoea 
prevalence at either the 12-month or 18-month visits. 
This finding is not consistent with those of 2015 Cochrane 
reviews on water chlorination24 and handwashing 
promotion,25 in which these interventions were estimated 
to reduce diarrhoea by about 25%. Most of the studies 
included in these reviews (and nearly all the studies 
which showed a significant effect on diarrhoea) had 
very high intervention doses—ie, daily-to-weekly 
contact between behaviour-change promoters and study 
participants—which was greater than the monthly 
contact delivered in SHINE. Although one water 
chlorination trial26 published since the 2015 Cochrane 
reviews showed a 36% reduction in diarrhoea with 
monthly behaviour change intervention contacts, at the 
midpoint between intervention visits staff visited to 
measure chlorine residuals—ie, participants received a 
visit about water chlorination every 2 weeks. Furthermore, 
several studies included in the Cochrane reviews showed 
no effect on diarrhoea, even with daily-to-weekly inter-
vention doses. Finally, follow-up studies27,28 suggest that 
the effect of these interventions on diarrhoea is not 
sustained once frequent intervention contacts end. Thus, 
adherence to handwashing and water-chlorination 
interventions (both highly dependent on sustained 
behaviour change) might not be sufficient to reduce 
diarrhoea when intervention dose is less frequent than 
monthly, even when behaviour-change messages are 
based on extensive formative research, delivered by 
highly trained workers, and accompanied by free 
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provision of soap and chlorine, as in SHINE. Intervention 
dose is often not reported in WASH behaviour-change 
studies and, to our knowledge, has not been extracted in 
any systematic review of WASH studies,24,25,29,30 suggesting 
that importance of very frequent sustained behaviour-
change promotion for home-based water chlorination 
and handwashing promotion might not be widely 
recognised.
Several other aspects of the trial could be important. 
First, we intervened at the household rather than 
community level, because we reasoned that young 
children spend most of their time within their own 
household. Increased community sanitation coverage, 
even in sparsely populated areas, might be required to 
affect growth. Although open defecation was reduced in 
the WASH households from around 50% to less 
than 1%, we estimate that community-level open 
defecation in the WASH clusters was reduced from 
around 55% to around 40% (data not shown). Decreased 
open defecation31 and higher sanitation coverage32 at the 
community level have been associated with reduced 
stunting.  A trial33 in Mali showed that communities 
randomised to a community-led sanitation-intervention 
had improved linear growth compared with control 
communities. Finally, although the SHINE WASH 
intervention considerably reduced geophagia and 
consumption of chicken faeces by maternal history, it 
did not prevent these behaviours (27% of WASH 
mothers still reported they had observed geophagia at 
the 12-month visit). Analyses of structured observation 
and in-depth interview data are underway, and will 
provide detailed information about how the play space 
was used and whether and by what magnitude this 
intervention interrupted faecal–oral microbial trans-
mission due to child exploratory play.
SHINE is the third trial in which a WASH intervention 
alone or in combination with an IYCF intervention had 
no effect on linear growth.34,35 Although these findings 
do not unequivocally prove that an integrated WASH–
nutrition approach will never improve linear growth 
in any context, these trials included more than 
18 000 children in three diverse settings where stunting 
is prevalent and environmental hygiene and infant diets 
are poor. We have three potential explanations for the 
lack of effects of WASH interventions on linear growth. 
First, our hypothesis could have been incorrect—
perhaps reduction of faecal ingestion does not reduce 
environmental enteric dysfunction, or perhaps preven-
tion of environmental enteric dysfunction does not 
improve linear growth. The cause and growth effects of 
environmental enteric dysfunction remain poorly 
understood. Laboratory analyses of biomarkers of 
environmental enteric dysfunction from the SHINE trial 
are underway.
Second, our hypothesis could have been correct, but 
the WASH interventions used were not effective enough 
to facilitate linear growth or, in two of the three trials, to 
reduce diarrhoea. Throughout history, linear growth and 
child health have improved after substantial socio-
economic development, as occurred after the industrial 
revolution in Europe and more recently in Latin 
America. These health benefits have been partly 
attributed to provision of piped water into homes, 
sewage systems, and flush toilets. For example, in Brazil, 
where stunting declined from 37% to 7% between 1996 
and 2007, expansion of water supply and sanitation 
services, particularly for the poorest people (ie, in the 
lowest wealth quintile), was one of four factors credited 
for approximately two-thirds of the stunting decline.36 
The absence of effects on linear growth and diarrhoea in 
SHINE suggests that the household-level interventions 
we implemented (point-of-use water chlorination, 
handwashing stations not connected to a water source, 
and improved pit latrines) might have little effect on 
child health, even on diarrhoea, unless the behaviour-
change intervention is sustained daily or weekly, as 
implemented by the WASH Benefits Bangladesh trial 
and other efficacy trials.34 Moreover, the WASH Benefits 
Bangladesh trial suggested that even with this level of 
sustained intervention dose, these interventions might 
not be efficacious enough to improve growth. One 
important intervention untested in any of the three trials 
is provision of an on-plot, sustained, high-quality water 
supply—the aspir ational goal of the Sustainable 
Development Goals (although most of the households in 
Bangladesh were less than 5 minutes’ walk from an 
improved water source). In summary, to achieve and 
sustain diarrhoea prevention at scale and improve linear 
growth might require new, innovative interventions that 
are less dependent on behaviour change and more 
efficacious in reducing faecal exposure—a paradigm 
shift away from how rural WASH programmes are 
delivered.
Third, the trials did not address intergenerational 
prenatal factors. Already at 1 month of age, mean length-
for-age Z score for infants in the SHINE trial was –0·85 
(SD 1·25) and 16% were stunted (data not shown) despite 
high rates of early initiation and exclusive breastfeeding16 
and installation of latrines and tippy taps during 
pregnancy. Preconception dietary supplementation of 
mothers (NCT01883193) and planned studies by our 
group to characterise the drivers of poor fetal growth 
during pregnancy could inform future preconception or 
prenatal interventions.
There is a large movement to scale up integrated 
WASH–nutrition interventions for stunting prevention.37 
The SHINE trial provides high-level evidence that 
elementary WASH interventions delivered at the 
household level in rural areas of low-income and middle-
income countries are unlikely to reduce stunting and 
might not reduce diarrhoea, and that implementation of 
these WASH interventions together with IYCF inter-
ventions will not reduce stunting more than implemen-
tation of IYCF alone. Our findings provide an urgent call 
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for greater investment in the WASH sector to identify 
and deliver more efficacious interventions. 
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